1 active not recruiting, 1 not yet recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Oropharyngeal HPV Squamous Cell Carcinoma: new trials by email Literature Review of Oropharyngeal HPV Squamous Cell Carcinoma trials Research Report on Oropharyngeal HPV Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 35 | 2027-01-31 | 2026-10-27 |
| Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer Concurrent Chemoradiotherapy, Dynamic Contrast-Enhanced MRI Perfusion (DCE-MRI) - Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal HPV Squamous Cell Carcinoma | Not applicable | Active not recruiting | Institute of Oncology Ljubljana | 30 | 2019-06-10 | 2026-02-17 |
Carcinoma, Squamous Cell (1) · Oropharyngeal Neoplasms (1) · Papillomavirus Infections (1) · Squamous Cell Carcinoma of Head and Neck (1)
Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Carcinoma, Squamous Cell (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Genital Diseases (1) · Head and Neck Neoplasms (1) · Infections (1) · Neoplasms by Site (1) · Neoplasms, Squamous Cell (1) · Otorhinolaryngologic Diseases (1) · Otorhinolaryngologic Neoplasms (1)
Chemoradiotherapy (1) · Dynamic Contrast Enhanced Magnetic Resonance Imaging (1) · Radiosurgery (1)
Abramson Cancer Center at Penn Medicine (1) · Institute of Oncology Ljubljana (1)
Slovenia (1)